33 results
Page 2 of 2
424B5
ko5mj008b1nm5kjh6yo9
26 Feb 21
Prospectus supplement for primary offering
5:10pm
424B5
lm3cbggj
24 Feb 21
Prospectus supplement for primary offering
5:16pm
6-K
1u5 4lsqkbpd82voxh
24 Feb 21
Current report (foreign)
4:16pm
424B5
govagh
20 Jul 20
Prospectus supplement for primary offering
9:21am
F-3
9ay8n qimfq0q3w1um
8 Jul 20
Shelf registration (foreign)
12:00am
20-F/A
3ofj2vq6hc 6b4o
29 Mar 19
Annual report (foreign) (amended)
4:23pm
6-K
EX-99.1
5pejakv9dv3 owcfjn
27 Feb 19
InflaRx Receives Approval to Initiate Phase IIa Clinical Trial with Lead CandidateIFX-1 in Pyoderma Gangraenosum
8:39am
424B4
9enp7rzu820
7 May 18
Prospectus supplement with pricing info
4:47pm
F-1
dnwdq856owmt51qtj
2 May 18
Registration statement (foreign)
7:10am
20-F
qyuj5v
29 Mar 18
Annual report (foreign)
12:00am